An interventional study of Non-alcoholic beer and Sparkling water in Alcohol Use Disorder (AUD), sponsored by Stanford University. Enrolling by invitation at 1 site in United States. Open to participants aged 21 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-07-20.
Sponsored by Stanford University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Alcoholism by Stanford University — 4 open to participants now, 4 under way, none of them phase 3. Alcoholism · Stanford University.
Among the 12 studies in Alcoholism by Stanford University, this one is the 6th largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2026, is one of 10 with no phase, and was the 12th registered.
1,678 studies on the registry are indexed under Alcoholism; 333 are open to participants now.
Browse Alcoholism studies →4 of the 12 studies in Alcoholism by Stanford University are open now, in 1 country. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 18–75
Stanford University · Sites in United States
Ages 18+ · Healthy volunteers
Stanford University · Sites in United States
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.
This study: 21 Years to 89 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 1999; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 60 is below the median of 88 across 1,433 interventional studies indexed under Alcoholism.
Median enrollment 60 across the 11 interventional studies, 409 across the 1 observational. Of the 6 that completed or were terminated, 2 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
2 of the studies in Alcoholism by Stanford University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06501677Stanford UniversityUsing EMA Data to Inform a Web-intervention for Couples Concerned About Drinking | 2026-12 |
| NCT05619185Stanford UniversityA SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners | 2027-08-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 12 studies in Alcoholism by Stanford University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This project will elucidate the acceptability and feasibility of incorporating provision of non-alcoholic beers into alcohol use disorder treatment, for patients interested in using non-alcoholic beers as part of their recovery from alcohol use disorder.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Participants will be eligible if they report on the screening survey:
Exclusion Criteria:
Participants will receive non-alcoholic beers (volume matching alcohol volume intake prior to alcohol use disorder treatment enrollment) for 6 weeks.
Other: Non-alcoholic beer
Participants will receive sparkling water (volume matching alcohol volume intake prior to alcohol use disorder treatment enrollment) for 6 weeks.
Other: Sparkling water
Participants will receive non-alcoholic beers and will be encouraged to consume the beverages to the extent they find useful/desirable during the 6-week study period.
Participants will receive sparkling water and will be encouraged to consume the beverages to the extent they find useful/desirable during the 6-week study period.
Participant Beverage Satisfaction (Acceptability)
"How satisfied were you with the beverages you received in this study?" with 5-pt scale response options ranging from "Very Unsatisfied" to "Very Satisfied." Higher scores \[split by condition\] will indicate greater acceptability.
Time frame: Assessed at the end of week 6
Participant Intention to Consume Assigned Beverage in the Future (Acceptability)
"Do you intend to consume the beverage type you received in the future?" with 5-pt scale response options ranging from "Definitely not" to "Definitely." Higher scores \[split by condition\] will indicate greater acceptability.
Time frame: Assessed at the end of week 6
Participant Likelihood of Recommending Beverage (Acceptability)
"Would you recommend the use of the beverage type you received for people who have alcohol use disorder?" with 5-pt scale response options ranging from "Definitely not" to "Definitely." Higher scores \[split by condition\] will indicate greater acceptability.
Time frame: Assessed at the end of week 6
Screened Out of Contacted (Feasibility)
Percentage of participants who completed the screening measure out of those who were contacted. Higher percentage will indicate greater feasibility.
Time frame: Beginning of recruitment to end of recruitment (approximately 3-6 months)
Eligible Out of Screened (Feasibility)
Percentage of participants who screen eligible out of those who were screened. Higher percentage will indicate greater feasibility.
Time frame: Beginning of recruitment to end of recruitment (approximately 3-6 months)
Enrolled Out of Eligible (Feasibility)
Percentage of participants who enrolled out of those who screened eligible. Higher percentage will indicate greater feasibility.
Time frame: Beginning of recruitment to end of recruitment (approximately 3-6 months)
Retention (Feasibility)
Percentage of participants who completed the study out of those who enrolled. Higher percentage \[split by condition\] will indicate greater feasibility.
Time frame: Beginning of recruitment to end of data collection (approximately 3-6 months)
Perception of Beverage Supply (Feasibility)
Percentage of participants whose response to "How was the supply of beverages you received throughout the study?" is "just right" \[as opposed to "too little" or "too much"\]. Higher percentage \[split by condition\] will indicate greater feasibility.
Time frame: Assessed at the end of week 6
Average Blood Alcohol Content Across 6 Weeks
Average blood alcohol content (measured via breathalyzer) across the 6-week period split by condition.
Time frame: Study weeks 1-6
Change in Blood Alcohol Content Across 6 Weeks
Slopes of blood alcohol content separated by condition for: a) start of treatment to pre-study and b) during the 6-week study period \[split by condition\].
Time frame: Treatment entry to week 6
Average Number of Days with Breathalyzer Readings
Average number of days with breathalyzer readings across the 6-week study.
Time frame: Assessed at 6 weeks.
Median Number of Breathalyzer Readings Among Days with Readings
Median number of breathalyzer readings among days with readings across the 6-week study.
Time frame: Assessed at 6 weeks.
Change in Reported Alcohol Use
Percentage of participants endorsing use of study-provided beverages who experienced (a) increase in alcohol use (defined as change in average use per week pre-study to average use per week across the study), (b) no change in alcohol use, (c) decrease in alcohol use \[split by condition\].
Time frame: Baseline to 6 weeks.
Perceived Change in Craving
Percentage of participants endorsing use of study-provided beverages who reported (a) increased in desire to drink alcohol, (b) no change in desire to drink alcohol, (c) decreased desire to drink alcohol \[split by condition\] in response to the item "When I drink the study provided beverages I experience…Less desire to drink alcohol; No change in my desire to drink alcohol; or More desire to drink alcohol.
Time frame: Assessed at 6 weeks.
Perceived Change in Alcohol Use
Percentage of participants endorsing use of study-provided beverages who reported (a) increased in alcohol use, (b) no change in alcohol use, (c) increased alcohol use \[split by condition\] in response to the item "Because I drink the study provided beverages I drink...Less alcohol than I otherwise would; The same amount of alcohol that I otherwise would; or More alcohol than I otherwise would."
Time frame: Assessed at 6 weeks.
Perceived Impact of Beverages on Recovery
Percentage of participants who responded to the item "What impact did the study provided beverages have on your recovery from alcohol use disorder?" with (a) Harmful; (b) No impact; or (c) Helpful \[split by condition\].
Time frame: Assessed at 6 weeks.
Plan to share: Yes — Data will be uploaded to the NIAAA data archive
Supporting information: Analytic code
Time frame: Analytic code, data, and data dictionary will be uploaded upon at the time of primary results submission to an academic journal.
No publications or documents are linked to this record.
Started May 2026 (actual). Primary completion is estimated for Oct 2026, 5 months after the start.
Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 5 months is below that.
Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.